NEW YORK, May 23, 2015 /PRNewswire/ -- Faruqi & Faruqi,
LLP, a leading national securities law firm, is investigating
potential securities fraud at IsoRay, Inc. ("IsoRay" or the
"Company") (NYSE MKT: ISR).
The investigation focuses on whether IsoRay and its executives
violated federal securities laws by manipulating the Company's lung
cancer study results in order to prop up the IsoRay stock
price.
On May 22, 2015, the market news
website TheStreet.com published an article titled
"IsoRay Takes Liberties With Lung Cancer Study Results to Prop Up
Stock Price," which reported that "To make up for the inability to
deliver revenue growth -- and prop up its stock price -- IsoRay
issues a lot of promotional press releases, some of which take
liberties with clinical data using clever, selective
editing." The article goes on to give the following example:
IsoRay recently trumpeted a 100% survival at five years in high
risk patients being treated with Cesium-131 without mentioning that
the comparable five year survival rate for patients undergoing
surgery alone is 98%.
Request more information now by clicking here:
www.faruqilaw.com/ISR. There is no cost or obligation to
you.
Take Action
If you invested in IsoRay stock or options and would like
to discuss your legal rights, please visit www.faruqilaw.com/ISR.
You can also contact us by calling Richard
Gonnello toll free at 877-247-4292 or at 212-983-9330 or by
sending an e-mail to rgonnello@faruqilaw.com. Faruqi & Faruqi,
LLP also encourages anyone with information regarding IsoRay's
conduct to contact the firm, including whistleblowers, former
employees, shareholders and others.
Attorney Advertising. The law firm responsible for this
advertisement is Faruqi & Faruqi, LLP
(www.faruqilaw.com). Prior results do not guarantee or predict
a similar outcome with respect to any future matter. We
welcome the opportunity to discuss your particular case. All
communications will be treated in a confidential manner.
Contact:
FARUQI & FARUQI, LLP
369 Lexington Avenue, 10th Floor
New York, NY 10017
Attn: Richard Gonnello, Esq.
rgonnello@faruqilaw.com
Telephone: (877) 247-4292 or (212) 983-9330
Logo -
http://photos.prnewswire.com/prnh/20120119/MM38856LOGO
To view the original version on PR Newswire,
visit:http://www.prnewswire.com/news-releases/isoray-shareholder-alert-faruqi--faruqi-llp-the-investigation-of-isoray-inc-and-its-officers-for-potential-securities-stock-fraud-in-connection-with-the-doctoring-of-study-results---isr-300088168.html
SOURCE Faruqi & Faruqi, LLP